Surface adsorption and peptide loss: container materials, low-concentration handling, and mass balance

A recurring frustration in peptide analytical work is the sample that arrives at the detector weaker than it should be. The vial was labeled correctly, the reconstitution math was right, the dilution series was prepared carefully — and yet the measured concentration comes in ten, twenty, sometimes fifty percent below the nominal value. Degradation is the usual first suspect, but in a large fraction of these cases the peptide has not degraded at all. It has simply stuck to something: the wall of the vial, the barrel of a pipette tip, the membrane of a syringe filter, the inner surface of a length of transfer tubing.

Surface adsorption is one of the least glamorous and most consequential variables in peptide handling. It is invisible, it scales inversely with concentration, and it produces errors that look exactly like degradation or like a low-potency lot. Understanding the underlying chemistry is what separates a real mass-balance problem from a handling artifact.

Why peptides stick

Adsorption at a solid–liquid interface is driven by the same non-covalent forces that govern peptide structure in general: hydrophobic interaction, electrostatic attraction, hydrogen bonding, and van der Waals contact. What makes peptides unusually prone to it is that a single molecule presents several of these surfaces at once. A twenty-residue peptide may carry a hydrophobic face, a cluster of positive charge, and multiple hydrogen-bond donors, all within a few nanometers. Whatever the container material is made of, some part of the peptide is likely to find it attractive.

Borosilicate glass is the classic offender for basic peptides. Silanol groups (Si–OH) on the glass surface deprotonate above roughly pH 3, leaving a net negative surface charge. Peptides rich in lysine, arginine, or histidine — which carry net positive charge at neutral pH — bind to that surface electrostatically. The interaction is strong enough that a dilute solution of a strongly basic peptide can lose a substantial fraction of its content to the walls of an untreated glass vial within minutes.

Polypropylene, the standard material for microcentrifuge tubes and pipette tips, has the opposite problem. It is uncharged and hydrophobic, so it binds peptides with exposed hydrophobic residues — long aliphatic side chains, aromatic residues, or lipidated peptides with a fatty acid chain. The lipidation strategies that have been characterized in the literature as extending circulating half-life also, predictably, make the resulting molecule considerably more adherent to plastic.

Filter membranes deserve their own mention because they combine both problems with an enormous surface area. A 0.22 µm syringe filter presents far more square centimeters of material to the solution than the vial it came from. Nylon and cellulose acetate membranes are notably retentive; polyethersulfone (PES) and polyvinylidene fluoride (PVDF) are generally described in the literature as lower-binding, and PVDF in particular is often specified for low-concentration protein and peptide work for that reason.

The concentration dependence

The property that makes adsorption so treacherous is that it is a surface phenomenon competing against a bulk phenomenon. The number of binding sites on a container wall is fixed by geometry. The number of peptide molecules in solution scales with concentration. At high concentration, the wall saturates quickly and the fraction of total peptide lost is negligible — a milligram-per-milliliter stock might lose a few micrograms and never notice. At low concentration, the same fixed number of surface sites can absorb a large proportion of everything present.

This produces a characteristic signature: recovery that gets worse as the sample gets more dilute. A stock solution assays correctly, the 1:10 dilution assays slightly low, the 1:100 dilution assays badly low, and the 1:1000 dilution may be almost entirely gone. Because a dilution series is exactly the tool used to build a calibration curve, adsorption does not just shift results — it bends the curve, compressing the low end and producing a nonlinear response that gets misattributed to detector behavior.

The effect also has a time dimension. Adsorption is not instantaneous; it approaches equilibrium over minutes to hours depending on the peptide, the surface, and the degree of agitation. A sample analyzed immediately after preparation and the same sample analyzed after sitting in an autosampler overnight can differ substantially, with no chemical change to the molecule whatsoever.

Distinguishing adsorption from degradation

The practical question in the laboratory is how to tell these apart, because they call for entirely different responses. Degradation means the material or the storage condition is the problem. Adsorption means the handling is.

Chromatography answers the question directly. Degradation generates new species: oxidation products, deamidation products, hydrolysis fragments, aggregates. These appear as new peaks, shoulders, or shifted retention times in a reversed-phase chromatogram, and the total integrated area attributable to peptide-related species stays roughly constant even as the main peak shrinks. Adsorption generates nothing. The main peak shrinks and no new peak appears anywhere — the missing material is not in the injected solution at all. A chromatogram showing a diminished main peak against a clean baseline with no new features is far more consistent with loss to surfaces than with chemical breakdown.

A second diagnostic is the container swap. Preparing the identical dilution in parallel in untreated glass, in low-binding polypropylene, and in a silanized or otherwise surface-treated vial, then assaying all three, isolates the variable cleanly. If the three differ meaningfully, the difference is adsorption, since the peptide has no way of knowing what it is sitting in other than through surface interaction.

A third approach is the carrier-protein or additive control. Introducing a small quantity of an inert carrier — a low concentration of a non-interfering protein, or a low concentration of a nonionic surfactant such as polysorbate 20 — occupies the surface sites competitively. If recovery improves sharply when a carrier is present, surface binding was the mechanism. This is a diagnostic tool rather than a universal fix; carriers and surfactants introduce their own analytical complications and are not appropriate for every method.

Mitigation and its limits

The general strategies described in the analytical literature fall into a few families. Surface treatment is the most direct: silanized glass, or vials and plates sold specifically as low-binding, chemically modify or coat the surface to reduce available binding sites. Solvent composition matters as well — adding a small percentage of organic modifier such as acetonitrile can reduce hydrophobic adsorption, and adjusting ionic strength or pH can weaken electrostatic binding by changing either the peptide’s net charge or the surface’s.

Minimizing surface exposure is the least technical and often the most effective measure. Fewer transfer steps means fewer surfaces. Avoiding unnecessary filtration, using the smallest practical container for the volume so the surface-to-volume ratio stays low, and pre-rinsing tips and vials with the solution being transferred so that binding sites saturate on material that is going to be discarded anyway are all standard practice in low-concentration work.

Each of these has costs. Surfactants can interfere with mass spectrometry and with some detection chemistries. Organic modifiers can affect peptide conformation and are not compatible with every downstream step. Carrier proteins are unsuitable whenever the assay is protein-sensitive. There is no universal solution, which is precisely why adsorption remains a persistent source of unexplained variance.

What this means for interpreting a result

The broader implication is a caution about attribution. When a measured concentration comes in below nominal, the chain of possible causes includes the manufacturing fill, the accuracy of the stated peptide content, chemical degradation during storage or shipping, an error in reconstitution arithmetic, an instrument calibration issue, and adsorptive loss during preparation. These are frequently collapsed into a single conclusion — that the material was underfilled or has degraded — when the evidence available does not actually distinguish among them.

A defensible attribution requires the diagnostic work: a chromatogram examined for new species rather than just for main-peak area, a parallel preparation in a different container material, a check of whether the discrepancy scales with dilution. Absent that, a low recovery number is an observation in search of a cause, not evidence about the material itself. Surface adsorption is a well-characterized physical process with predictable behavior, and it accounts for a meaningful share of the low-concentration recovery problems that get filed under other explanations.